CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- 8-K Event Other events
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- SC 13G Stake Amended Statement of Ownership
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- CT ORDER Other Confidential Order
- 8-K Event Other events
- 424B4 Offering Prospectus
- POS EX Other Post-effective Amendment
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 28 of 74 · 1,467 filings